Medical Research News

RSS

Researchers challenge the traditional understanding of how histone deacetylase inhibitors function

Researchers at Baylor College of Medicine and collaborating institutions are challenging the traditional understanding of how cancer drugs called histone deacetylase (HDAC) inhibitors function.

5 Jun 2026

Integrated care reduces hospital visits for adults with disabilities

University of Cincinnati and Ohio State University researchers have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not.

5 Jun 2026

Three decades of progress since the discovery of senescence-associated beta-galactosidase

A new review was published in Volume 18 of Aging on May 15, 2026, titled "Blue period – features of senescence 30 years after beta-galactosidase."

5 Jun 2026

Grant fuels research into SYNGAP1-linked behavioral abnormalities

CURE SYNGAP1 501(c)(3) is pleased to announce a $130,000 grant to Dr. Helen Willsey and Dr. David Kastner at the University of California, San Francisco (UCSF).

5 Jun 2026

Study links common sleep behaviors to signs of brain aging

How we sleep may have lasting impacts for our brain health as we age. A new University of Arizona study has found that several common sleep behaviors may be linked to signs of brain aging.

5 Jun 2026

Popular supplement creatine supercharges critical immune cells fighting cancer

Creatine, the organic acid that is popularly taken as a supplement by athletes and bodybuilders, supercharges a critical class of immune cells that activate and prepare the body's key cancer-fighters, according to new UCLA research.

5 Jun 2026

Study evaluates how facial aging features influence age perception in women

This study enrolled 308 Chinese women aged 15–65 years to explore the relationship between chronological age, perceived age, and facial aging manifestations.

5 Jun 2026

Study validates research models for tracking circular extra-chromosomal DNA

Damage to DNA in cancer cells can lead to pieces breaking off chromosomes and floating away, like icebergs cracking off from a glacier.

5 Jun 2026

Maternal vaccination provides protection against RSV-associated hospitalization in early infancy

A study led by researchers at the University of Pittsburgh and UPMC published today in JAMA Network Open, a peer-reviewed journal of the American Medical Association, found that vaccination against respiratory syncytial virus (RSV) during pregnancy reduced the risk of hospitalization in young infants by nearly 70%.

5 Jun 2026

Flu drugs may reduce cognitive decline in people with HIV

A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection, reports a new study led by Northwestern University that began with blood samples from people with HIV and extended into preclinical drug trials.

5 Jun 2026

Home sewage overflows expose residents to dangerous drug-resistant bacteria

A new study shows that sewage overflows in homes can expose people to bacteria that can make them sick, including antibiotic-resistant and multidrug resistant bacteria which can make infections difficult to treat.

5 Jun 2026

Favorable lifestyle factors reduce dementia risk across key genetic profiles

With dementia cases expected to nearly triple worldwide by 2050, researchers are increasingly focused on identifying ways to prevent or delay the disease.

5 Jun 2026

Hidden junk DNA could play decisive role in cancer

Many repetitive regions of the genome have been considered "junk DNA" because the technologies available did not allow them to be studied at sufficient resolution.

5 Jun 2026

Study links pre-bedtime smartphone use to longer teen late nights

A new study to be presented at the SLEEP 2026 annual meeting found that on evenings when adolescents used their smartphone before bedtime more than their own usual, they used their smartphone for longer later that same night, compared with nights when they used their phones less before bedtime.

5 Jun 2026

Review highlights TIGIT as a promising second-generation immunotherapy target

Malignant tumors remain a major threat to human health, with conventional therapies and first-generation immune checkpoint inhibitors (ICIs) facing limitations like drug resistance and low response rates.

5 Jun 2026

Antibody fragment offers safer alternative for Alzheimer disease treatment

In 2025, the European Medicines Agency approved two antibodies for Alzheimer's disease: lecanemab (Leqembi, from Biogen) and donanemab (KisunlaTM, from Eli Lilly and Company), both based on immunotherapy (the use of molecules from the immune system to treat diseases).

5 Jun 2026